• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CAPENTIER EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL AORTIC BIOPROSTHESIS; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CAPENTIER EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL AORTIC BIOPROSTHESIS; REPLACEMENT HEART VALVE Back to Search Results
Model Number 3300TFX
Device Problems Calcified (1077); Degraded (1153); Gradient Increase (1270); Inadequacy of Device Shape and/or Size (1583)
Patient Problem Heart Failure/Congestive Heart Failure (4446)
Event Date 04/01/2021
Event Type  Injury  
Manufacturer Narrative
The device was not returned to edwards for evaluation due to covid-19 infection.Patient prosthesis mismatch (ppm) is present when the effective orifice area of the inserted prosthetic valve is too small in relation to body size.Its main hemodynamic consequence is to generate higher than expected gradients through a normally functioning prosthetic valve.Ppm has been shown to be associated with worse hemodynamic function, less regression of left ventricular hypertrophy, more cardiac events, and lower survival.The root cause of the event was likely due to patient conditions and operational context.If additional information is received a supplemental mdr will be submitted.Edwards lifesciences will continue to monitor all reported events.
 
Event Description
It was reported that a patient with a 23mm 3300tfx aortic valve implanted for 4 years, 9 months underwent redo aortic valve replacement due to patient-prosthesis mismatch, calcification, moderate to severe nonrheumatic aortic stenosis, thickened and sclerosed leaflets.The patient presented with nyha class iii heart failure.A 25mm 11500a aortic valve was implanted in replacement.Post-operative tee revealed excellent valve function with no significant perivalvular leaks.Patient tolerated the procedure well.Postoperatively, the patient developed intermittent chb and was paced and underwent a placement of a permanent pacemaker.The patient was discharged home on pod # 5.
 
Manufacturer Narrative
Manufacturer narrative: updated sections d4-expiration date, h4, and h6 (type of investigation).The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.
 
Manufacturer Narrative
Updated section h6: component codes, type of investigation, investigation findings, and investigation conclusions.The event occurred due to procedural factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPENTIER EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL AORTIC BIOPROSTHESIS
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key11749800
MDR Text Key252265001
Report Number2015691-2021-02732
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
PMA/PMN Number
P860057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 06/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/22/2020
Device Model Number3300TFX
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age65 YR
Patient Weight79
-
-